Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 3
1973 4
1974 2
1975 2
1976 2
1977 7
1978 3
1986 1
1987 1
1988 1
1989 1
1991 2
1992 2
1993 1
2002 1
2005 2
2008 1
2009 2
2010 3
2011 1
2012 2
2013 2
2014 3
2015 5
2016 2
2017 6
2018 2
2019 1
2020 3
2021 2
2022 7
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Withdrawal of Immunomodulators or TNF Antagonists in Patients With Inflammatory Bowel Diseases in Remission on Combination Therapy: A Systematic Review and Meta-analysis.
Katibian DJ, Solitano V, Polk DB, Nguyen T, Ma C, Syal G, Kobayashi T, Hibi T, Buhl S, Ainsworth MA, Jairath V, Singh S. Katibian DJ, et al. Among authors: buhl s. Clin Gastroenterol Hepatol. 2024 Jan;22(1):22-33.e6. doi: 10.1016/j.cgh.2023.08.039. Epub 2023 Sep 15. Clin Gastroenterol Hepatol. 2024. PMID: 37716619 Review.
The AP-2 family of transcription factors.
Eckert D, Buhl S, Weber S, Jäger R, Schorle H. Eckert D, et al. Among authors: buhl s. Genome Biol. 2005;6(13):246. doi: 10.1186/gb-2005-6-13-246. Epub 2005 Dec 28. Genome Biol. 2005. PMID: 16420676 Free PMC article. Review.
Discontinuation of Infliximab Therapy in Patients with Crohn's Disease.
Buhl S, Steenholdt C, Brynskov J, Christensen KR, Dorn-Rasmussen M, Thomsen OØ, Bendtzen K, Klausen TW, Dahlerup JF, Thorsgaard N, Jahnsen J, Molazahi A, Pedersen N, Kjeldsen J, Almer S, Dahl EE, Vind I, Cannon AG, Marsal J, Sipponen T, Agnholt JS, Kievit HAL, Aure SL, Martinsen L, Meisner S, Hansen JM, Ainsworth MA. Buhl S, et al. NEJM Evid. 2022 Aug;1(8):EVIDoa2200061. doi: 10.1056/EVIDoa2200061. Epub 2022 Jun 14. NEJM Evid. 2022. PMID: 38319804
Novel materials for biofilm reactors and their characterization.
Müller-Renno C, Buhl S, Davoudi N, Aurich JC, Ripperger S, Ulber R, Muffler K, Ziegler Ch. Müller-Renno C, et al. Among authors: buhl s. Adv Biochem Eng Biotechnol. 2014;146:207-33. doi: 10.1007/10_2013_264. Adv Biochem Eng Biotechnol. 2014. PMID: 24291814 Review.
Integrated care for older multimorbid heart failure patients: protocol for the ESCAPE randomized trial and cohort study.
Zelenak C, Nagel J, Bersch K, Derendorf L, Doyle F, Friede T, Herbeck Belnap B, Kohlmann S, Skou ST, Velasco CA, Albus C, Asendorf T, Bang CA, Beresnevaite M, Bruun NE, Burg MM, Buhl SF, Gaede PH, Lühmann D, Markser A, Nagy KV, Rafanelli C, Rasmussen S, Søndergaard J, Sørensen J, Stauder A, Stock S, Urbinati S, Riva DD, Wachter R, Walker F, Pedersen SS, Herrmann-Lingen C; ESCAPE consortium. Zelenak C, et al. Among authors: buhl sf. ESC Heart Fail. 2023 Jun;10(3):2051-2065. doi: 10.1002/ehf2.14294. Epub 2023 Mar 12. ESC Heart Fail. 2023. PMID: 36907651 Free PMC article.
Leukemogenic transformation by HOXA cluster genes.
Bach C, Buhl S, Mueller D, García-Cuéllar MP, Maethner E, Slany RK. Bach C, et al. Among authors: buhl s. Blood. 2010 Apr 8;115(14):2910-8. doi: 10.1182/blood-2009-04-216606. Epub 2010 Feb 3. Blood. 2010. PMID: 20130239 Free article.
75 results